BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36076204)

  • 1. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
    Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
    Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
    Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
    Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study.
    Assefa A; Ali A; Deressa W; Tsegaye W; Abebe G; Sime H; Kebede A; Jima D; Kassa M; Abreha T; Teka H; Solomon H; Malone J; Shi YP; Zhou Z; Reithinger R; Hwang J
    Malar J; 2018 Oct; 17(1):388. PubMed ID: 30367627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
    Recht J; Ashley EA; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
    Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
    Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-6-Phosphate Dehydrogenase Deficiency Genetic Variants in Malaria Patients in Southwestern Ethiopia.
    Carter TE; Mekonnen SK; Lopez K; Bonnell V; Damodaran L; Aseffa A; Janies DA
    Am J Trop Med Hyg; 2018 Jan; 98(1):83-87. PubMed ID: 29141760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
    Tsegaye A; Golassa L; Mamo H; Erko B
    Malar J; 2014 Nov; 13():438. PubMed ID: 25406667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G6PD deficiency in malaria endemic areas of Nepal.
    Marasini B; Lal BK; Thapa S; Awasthi KR; Bajracharya B; Khanal P; Neupane S; Jha SN; Acharya S; Iama S; Koirala M; Koirala D; Bhandari S; Mahato RK; Chaudhary A; Ghimire P; Magar RG; Bhattarai RK; Gornsawun G; Penpitchaporn P; Bancone G; Acharya BP
    Malar J; 2020 Aug; 19(1):287. PubMed ID: 32787970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
    Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
    Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
    Shitaye G; Gadisa E; Grignard L; Shumie G; Chali W; Menberu T; Belachew M; Tegegn G; Challi S; Curry J; Mahey L; Hailu T; Mamo H; Menon M; Balcha T; Aseffa A; Drakeley C; Bousema T; Tadesse FG
    Malar J; 2018 Aug; 17(1):281. PubMed ID: 30071859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
    Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
    Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
    Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.